Skinvisible Inc. (SKVI) news stock charts
Skinvisible Inc. (SKVI/SKVI.OB) Investment Summary:
Skinvisible, Inc. together with its subsidiary, Skinvisible Pharmaceuticals, Inc., engages in the development and manufacture of topical polymer-based delivery system technologies and formulations for combining hydrophilic and hydrophobic polymer emulsions. Its polymer delivery vehicles allow normal skin respiration and perspiration, which are used in antimicrobial hand sanitizer lotions, suncare products, skincare moisturizers, and sunless tanning products, as well as in various dermatology products for various skin disorders. The company also provides antibacterial/antimicrobial hand sanitizer formulations that offer skincare solutions for the healthcare, food service, industrial, cosmetic...www.skinvisible.com
4 Employees
Founded in 1998
SKINVISIBLE INC (SKVI:OTC Bulletin Board Market)
LAST $0.11 USD
CHANGE TODAY +0.01 10.00%
VOLUME 19.5K
As of 8:10 PM 03/12/10 All times are local (Market data is delayed by at least 15 minutes).
Snapshot of SKINVISIBLE INC (SKVI)
|
OPEN
$0.10
|
PREVIOUS CLOSE
$0.10
|
|
|
DAY HIGH
$0.11
|
DAY LOW
$0.10
|
|
|
52 WEEK HIGH
07/28/09 - $0.25
|
52 WEEK LOW
04/15/09 - $0.03
|
|
|
MARKET CAP
10.3M
|
AVERAGE VOLUME 10 D
90.6K
|
|
|
EPS TTM
$-0.01
|
SHARES OUTSTANDING
93.5M
|
|
|
SKVI Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for SKINVISIBLE INC (SKVI)
Skinvisible Inc. Inks Canadian Agreement for DermSafe
12/11/2009
DermSafe and Alto Pharmaceuticals have entered into a license agreement for DermSafe(R), Skinvisible 's antimicrobial hand sanitizer lotion that recently completed clinical studies proving it kills the H1N1 virus. Under the terms of the agreement, Alto will pay Skinvisible an upfront license fee for the exclusive manufacturing and the commercial /professional use marketing rights for DermSafe in Canada. Skinvisible will also receive a royalty from product sales. DermSafe claims its product does not contain alcohol and therefore is non-drying to the skin, and that schools, penitentiaries and other groups with safety concerns have discontinued the use of alcohol-based hand sanitizers. The active ingredient in DermSafe is chlorhexidine gluconate, an ingredient approved by Health Canada under the Human Use Antiseptic Drugs Monograph. This ingredient has been safely used in hospitals worldwide as a pre-surgical scrub as well as in dental applications. This license agreement is the second DermSafe agreement signed by Skinvisible. The DermSafe licensee, Mayquest Pharmaceuticals, based in Singapore, recently received approval to import DermSafe to Singapore and will commence commercial /professional sales in January 2010.
Skinvisible and Alto Pharmaceuticals Enter into a License Agreement
12/9/2009
Skinvisible Inc. and Alto Pharmaceuticals have entered into a license agreement for DermSafe(R), Skinvisible's antimicrobial hand sanitizer lotion that recently completed clinical studies proving it kills the H1N1 virus. Under the terms of the agreement, Alto will pay Skinvisible an upfront license fee for the exclusive manufacturing and the commercial /professional use marketing rights for DermSafe in Canada. Skinvisible will also receive a royalty from product sales.
New Clinical Study Proves Skinvisible's DermSafe Kills the H1N1 Swine Flu Virus
11/12/2009
Skinvisible Inc. announced that it has successfully completed a new clinical study proving that its hand sanitizer lotion DermSafe(R) kills/inactivates the H1N1 virus on humans. This in-vivo study proves that DermSafe meets the criteria set-out by internationally accepted study guidelines to show efficacy against the H1N1 'swine flu' virus. The study, performed at the independent testing laboratory Bioscience Laboratories Inc., required that the subjects' finger pads be contaminated with the H1N1 virus and then examined according to the American Society for Testing and Materials (ASTM) Standards. The results of the study proved that DermSafe killed the virus to the same detection level as 70% alcohol. In some countries, this study allows Skinvisible to submit data for approval to include 'Kills H1N1' on the product label. This further confirms the efficacy of DermSafe as previously announced in an in-vitro study conducted at Retroscreen Virology, where DermSafe also achieved a 99.99% kill/inactivation of the H1N1 virus.
Skinvisible Inc. financial resources
SKVI Competitors
| Company | Last | Change | |
| No competitor information is available for SKVI. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | SKVI | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 25.9x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 26.3x |
|
|
SKVI |
||
|
SKVI transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About Skinvisible Inc.
Skinvisible Licensee Receives Reorder from Walgreens
2010-02-25 02:24:57
Quote: Terry Howlett, President and CEO of Skinvisible Pharmaceuticals, Inc. "We anticipate further growth as their marketing campaign which includes print, radio and TV, ramps up over the next several weeks. We have recently shipped additional Invisicare polymer to fulfill their Walgreens re-order and we foresee continuous orders as they expand their distribution with additional mass merchandisers and pharmacy chains. Additionally, they are experiencing brisk sales of Safe4Hours skin protectant in Can...Read article
Skinvisible's Safe4Hours Promotion in Walgreens Expands
2010-02-15 02:00:05
Quote: We have also incorporated a TV marketing campaign into
this promotion, profiling the dual benefits of Safe4Hours in major US
markets.Along with being a first aid antiseptic that protects you from
infection, Safe4Hours is also a skin protectant that protects your hands,
face and body from the drying effects of weather year round."Safe4Hours First Aid Antiseptic Skin Protectant is an important product to
stop the spread of skin infections.Athletes in particular, including
professionals, amateurs a...Read article
New Clinical Study Proves Skinvisible's DermSafe Kills the H1N1 Swine Flu Virus
2010-02-12 04:12:01
Quote: In some countries, this study allows Skinvisible to submit data for approval to include "Kills H1N1" on the product label. This further confirms the efficacy of DermSafe as previously announced in an in-vitro study conducted at Retroscreen Virology, where DermSafe also achieved a 99.99% kill / inactivation of the H1N1 virus.
Furthermore, DermSafe was also successfully tested in an in-vivo bacterial hand disinfection study using the European Standard Method. This study method is used in a number...Read article
Skinvisible Signs License Agreement for DermSafe to Fight H1N1
2010-02-12 04:12:01
Quote: for the rights for DermSafe(R), Skinvisible's patented antimicrobial hand sanitizer lotion proven to kill the H1N1 swine flu virus. The license agreement includes Singapore, Malaysia, Thailand, Indonesia and the Philippines.
Under the terms of the agreement, Mayquest will pay an upfront license fee in milestones for the exclusive manufacturing and marketing rights for DermSafe in the territory. Skinvisible will also receive on-going royalties from product sales.
"Mayquest is an excellent partn...Read article
Skinvisible Announces Canadian License Agreement for DermSafe
2010-02-12 04:12:00
Quote: SKVINewswww.altopharma.com), a dermatology-focused company based in Toronto, announced today they have entered into a license agreement for DermSafe(R), Skinvisible's antimicrobial hand sanitizer lotion that recently completed clinical studies proving it kills the H1N1 virus. Under the terms of the agreement, Alto will pay Skinvisible an upfront license fee for the exclusive manufacturing and the commercial / professional use marketing rights for DermSafe in Canada. Skinvisible will also receive...Read article
Skinvisible Licensee Receives Reorder from Walgreens
2010-02-12 04:11:59
Quote: Terry Howlett, President and CEO of Skinvisible Pharmaceuticals, Inc. “We anticipate further growth as their marketing campaign which includes print, radio and TV, ramps up over the next several weeks. We have recently shipped additional Invisicare polymer to fulfill their Walgreens re-order and we foresee continuous orders as they expand their distribution with additional mass merchandisers and pharmacy chains. Additionally, they are experiencing brisk sales of Safe4Hours skin prote...Read article
Skinvisible Licensee Announces Agreement With Walgreens
2010-02-12 04:11:59
Quote: JD Nelson currently licenses Safe4Hours Hand Sanitizer from Skinvisible. This new product, which represents the first of JD Nelson's product line extensions, was developed by Skinvisible using its patented Invisicare(R) technology which binds products to the skin, resisting both wash off and perspiration and provides a controlled release of the active ingredient.
Walgreens, with over 7,000 retail drugstore locations in the United States, will launch Safe4Hours(R) First Aid Antiseptic Skin Prote...Read article
Skinvisible's Safe4Hours Promotion in Walgreens Expands
2010-02-12 04:11:58
Quote: We have also incorporated a TV marketing campaign into
this promotion, profiling the dual benefits of Safe4Hours in major US
markets.Along with being a first aid antiseptic that protects you from
infection, Safe4Hours is also a skin protectant that protects your hands,
face and body from the drying effects of weather year round."Safe4Hours First Aid Antiseptic Skin Protectant is an important product to
stop the spread of skin infections.Athletes in particular, including
professionals, amateurs a...Read article
Skinvisible Licensee Receives Reorder from Walgreens
2010-01-29 03:08:15
Quote: Terry Howlett, President and CEO of Skinvisible Pharmaceuticals, Inc. “We anticipate further growth as their marketing campaign which includes print, radio and TV, ramps up over the next several weeks. We have recently shipped additional Invisicare polymer to fulfill their Walgreens re-order and we foresee continuous orders as they expand their distribution with additional mass merchandisers and pharmacy chains. Additionally, they are experiencing brisk sales of Safe4Hours skin prote...Read article
Skinvisible Licensee Announces Agreement With Walgreens
2010-01-14 02:04:51
Quote: JD Nelson currently licenses Safe4Hours Hand Sanitizer from Skinvisible. This new product, which represents the first of JD Nelson's product line extensions, was developed by Skinvisible using its patented Invisicare(R) technology which binds products to the skin, resisting both wash off and perspiration and provides a controlled release of the active ingredient.
Walgreens, with over 7,000 retail drugstore locations in the United States, will launch Safe4Hours(R) First Aid Antiseptic Skin Prote...Read article
Skinvisible Announces Canadian License Agreement for DermSafe
2009-12-11 06:25:43
Quote: SKVINewswww.altopharma.com), a dermatology-focused company based in Toronto, announced today they have entered into a license agreement for DermSafe(R), Skinvisible's antimicrobial hand sanitizer lotion that recently completed clinical studies proving it kills the H1N1 virus. Under the terms of the agreement, Alto will pay Skinvisible an upfront license fee for the exclusive manufacturing and the commercial / professional use marketing rights for DermSafe in Canada. Skinvisible will also receive...Read article
Skinvisible Receives Comprehensive Patent in China
2009-12-01 04:43:17
Quote: SKVINews;www.skinvisible.com), is pleased to announce that it has been granted a comprehensive patent in China for Invisicare; Skinvisible's polymer delivery system that enhances topically delivered products. This patent covers the areas of 'Topical Composition', 'Topical Composition Precursor', and 'Methods for Manufacturing and Using'.
This patent in China will assist Skinvisible in solidifying on-going negotiations with potential licensees and to continue to expand its offerings into Asia. R...Read article
Skinvisible Prepares as H1N1 (Swine Flu) Virus Spreads
2009-11-30 01:21:10
Quote: The spread of this virus and the declaration of a pandemic by the World Health Organization (WHO) has increased Skinvisible's efforts in the global licensing of DermSafe.
On June 11, 2009, WHO raised their pandemic threat to a Phase 6 -- "the virus is contagious, spreading easily from one person to another and from one country to another." On the same date over 30,000 cases were confirmed in 74 countries. Less than one month later, the confirmed cases tripled in number to over 94,000, and the n...Read article
Invisicare Approved for Additional U.S. Patent
2009-11-30 01:21:09
Quote: With this new patent Skinvisible is allowed additional protection for its Invisicare technology under the category of Topical Composition and Topical Composition Precursor. The United States patent office has also extended the life of this patent a further one and a half years.
"This announcement strengthens Skinvisible's intellectual property protection for our proprietary formulated dermatology and consumer goods products that we have developed using Invisicare," said Mr. Terry Howlett, Presi...Read article
Skinvisible Signs License Agreement for DermSafe to Fight H1N1
2009-11-30 01:21:08
Quote: for the rights for DermSafe(R), Skinvisible's patented antimicrobial hand sanitizer lotion proven to kill the H1N1 swine flu virus. The license agreement includes Singapore, Malaysia, Thailand, Indonesia and the Philippines.
Under the terms of the agreement, Mayquest will pay an upfront license fee in milestones for the exclusive manufacturing and marketing rights for DermSafe in the territory. Skinvisible will also receive on-going royalties from product sales.
"Mayquest is an excellent partn...Read article
SKINVISIBLE INC Files SEC form 10-Q, Quarterly Report
2009-11-30 01:21:08
Quote: All patents with
Invisicare are owned by Skinvisible.
Patent protection is important to our company. Pharmaceutical companies are
pursuing new or improved revenue streams along with protecting their own
intellectual properties. Invisicare allows companies to sell a patent-protected
product that has been revitalized with new benefits, giving them a new story to
help combat generic competitors. A prescription dermatology product can generate
$100 plus million per year; some even $200 plus million ...Read article
SKINVISIBLE INC Files SEC form 10-Q, Quarterly Report
2009-11-30 01:21:07
Quote: All patents with
Invisicare are owned by Skinvisible.
Patent protection is important to our company. Pharmaceutical companies are
pursuing new or improved revenue streams along with protecting their own
intellectual properties. Invisicare allows companies to sell a patent-protected
product that has been revitalized with new benefits, giving them a new story to
help combat generic competitors. A prescription dermatology product can generate
sales of $100 plus million per year; some even $200 plus...Read article
New Clinical Study Proves Skinvisible's DermSafe Kills the H1N1 Swine Flu Virus
2009-11-30 01:21:07
Quote: In some countries, this study allows Skinvisible to submit data for approval to include "Kills H1N1" on the product label. This further confirms the efficacy of DermSafe as previously announced in an in-vitro study conducted at Retroscreen Virology, where DermSafe also achieved a 99.99% kill / inactivation of the H1N1 virus.
Furthermore, DermSafe was also successfully tested in an in-vivo bacterial hand disinfection study using the European Standard Method. This study method is used in a number...Read article
Would you like to leave a comment about Skinvisible Inc. SKVI/SKVI.OB
Find out what social network information about Skinvisible Inc. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides Skinvisible Inc.'s Stock there is more great penny stock and market information at Realpennies